ACH

Accendra Health Inc

• Simply Wall St·05/13 13:35

  Accendra Health (ACH) Q1 Loss Narrows Challenging Bearish Profitability Narratives

• Dow Jones·05/12 22:22

  Accendra Health Is Maintained at Neutral by UBS

• Benzinga·05/12 22:12

  UBS Maintains Neutral on Accendra Health, Raises Price Target to $4.5

• Dow Jones·05/12 18:56

  Accendra Health Is Maintained at Buy by Citigroup

• Dow Jones·05/12 18:56

  Accendra Health Price Target Raised to $5.00/Share From $3.25 by Citigroup

• Benzinga·05/12 18:47

  Citigroup Maintains Buy on Accendra Health, Raises Price Target to $5

• Dow Jones·05/12 11:42

  Accendra Health Is Maintained at Outperform by Baird

• Dow Jones·05/12 11:42

  Accendra Health Price Target Raised to $6.00/Share From $5.00 by Baird

• Benzinga·05/12 11:32

  Baird Maintains Outperform on Accendra Health, Raises Price Target to $6

• NASDAQ·05/11 19:33

  Notable Monday Option Activity: PDFS, ACH, EOSE

• Seeking Alpha·05/11 18:33

  Accendra Health Makes Progress Addressing Its Debt Load

• The Motley Fool·05/11 17:38

  Accendra Health (ACH) Q1 2026 Earnings Transcript

• Seeking Alpha·05/11 17:31

  Accendra signals up to $115M deleveraging through balance sheet optimization while extending maturities to 2032-2033

• Dow Jones·05/11 14:33

  Accendra Health Shares Gain on Narrowed Loss, Adjusted EPS Beat

• Benzinga·05/11 13:54

  Accendra Health Affirms FY2026 Sales Guidance of $2.550B-$2.650B vs $2.590B Est